Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

According to the Cleaveland Clinic, GLP-1 agonists (glucagon-like peptide-1 receptor agonists) are injectable medications ...

“Semaglutide has been in the US for more than eight years now. In India also, the oral version of this molecule is there for ...

Tennis legend Serena Williams has sparked conversations around fitness and health after reports of her weight loss journey ...

Uagnda's Dei BioPharma Ltd has announced that the U.S. Food and Drug Administration has accepted the development plan for two of its novel biological drugs, liraglutide and semaglutide, which are used ...

Serena Williams, who was once celebrated for her curves, has confirmed that the reason for her newly trim figure is the use ...

Serena Williams revealed how she turned her health around with the help of a GLP-1 medication after she struggled to lose ...

Serena Williams revealed she uses GLP-1 medication to aid weight loss after motherhood. This highlights a shift towards combining medicine with lifestyle for obesity management.

Researchers have developed fluorescent probes, daLUXendins, to track dual agonist drugs like tirzepatide in live tissues. The ...

Serena Williams, the tennis legend with 23 Grand Slam singles titles, has always been admired for her athletic prowess and ...

Serena Williams' new advertisement for GLP-1 treatments has ignited a wave of mixed reactions, as fans question the implications of her endorsement on health and beauty standards.